PFIZER INC Accumulated Other Comprehensive Income
PFIZER INC (PFE) had Accumulated Other Comprehensive Income of -$7.22 billion as of 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-04
- 2026-06-28: Accumulated Other Comprehensive Income (Loss), Net of Tax -$7.22B.
- 2026-03-29: Accumulated Other Comprehensive Income (Loss), Net of Tax -$7.20B.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$8.07B.
- 2025-09-28: Accumulated Other Comprehensive Income (Loss), Net of Tax -$8.07B.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-28 | -$7.22B 10-Q · filed 2026-08-04 | |
| 2026-03-29 | -$7.20B 10-Q · filed 2026-05-05 | |
| 2025-12-31 | -$8.07B 10-Q · filed 2026-08-04 | |
| 2025-09-28 | -$8.07B 10-Q · filed 2025-11-04 | |
| 2025-06-29 | -$8.44B 10-Q · filed 2025-08-05 | |
| 2025-03-30 | -$8.58B 10-Q · filed 2025-05-05 | |
| 2024-12-31 | -$7.84B 10-K · filed 2026-02-26 | |
| 2024-09-29 | -$7.97B 10-Q · filed 2024-11-04 | |
| 2024-06-30 | -$7.82B 10-Q · filed 2024-08-05 | |
| 2024-03-31 | -$7.76B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | -$7.96B 10-K · filed 2025-02-27 | |
| 2023-10-01 | -$7.97B 10-Q · filed 2023-11-08 | |
| 2023-07-02 | -$8.10B 10-Q · filed 2023-08-09 | |
| 2023-04-02 | -$8.29B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$8.30B 10-K · filed 2024-02-22 | |
| 2022-10-02 | -$8.22B 10-Q · filed 2022-11-09 | |
| 2022-07-03 | -$7.12B 10-Q · filed 2022-08-10 | |
| 2022-04-03 | -$6.16B 10-Q · filed 2022-05-11 | |
| 2021-12-31 | -$5.90B 10-K · filed 2023-02-23 | |
| 2021-10-03 | -$5.65B 10-Q · filed 2021-11-12 | |
| 2021-07-04 | -$4.76B 10-Q · filed 2021-08-12 | |
| 2021-04-04 | -$4.66B 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$5.31B 10-K · filed 2022-02-24 | -$11.69B 10-K · filed 2021-02-25 |
| 2020-09-27 | -$12.68B 10-Q · filed 2020-11-05 | |
| 2020-06-28 | -$13.25B 10-Q · filed 2020-08-06 | |
| 2020-03-29 | -$13.13B 10-Q · filed 2020-05-07 | |
| 2019-12-31 | -$11.64B 10-K · filed 2021-02-25 | |
| 2019-09-29 | -$11.80B 10-Q · filed 2019-11-07 | |
| 2019-06-30 | -$11.54B 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$10.92B 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$11.28B 10-K · filed 2020-02-27 | |
| 2018-09-30 | -$10.42B 10-Q · filed 2018-11-08 | |
| 2018-07-01 | -$10.00B 10-Q · filed 2018-08-09 | |
| 2018-04-01 | -$9.40B 10-Q · filed 2018-05-10 | |
| 2018-01-01 | -$10.23B 10-K · filed 2019-02-28 | |
| 2017-12-31 | -$9.32B 10-K · filed 2019-02-28 | |
| 2017-10-01 | -$9.16B 10-Q · filed 2017-11-09 | |
| 2017-07-02 | -$10.18B 10-Q · filed 2017-08-10 | |
| 2017-04-02 | -$10.59B 10-Q · filed 2017-05-11 | |
| 2016-12-31 | -$11.04B 10-K · filed 2018-02-22 | |
| 2016-10-02 | -$8.21B 10-Q · filed 2016-11-10 | |
| 2016-07-03 | -$8.89B 10-Q · filed 2016-08-11 | |
| 2016-04-03 | -$9.52B 10-Q · filed 2016-05-12 | |
| 2015-12-31 | -$9.52B 10-K · filed 2017-02-23 | |
| 2015-09-27 | -$9.17B 10-Q · filed 2015-11-05 | |
| 2015-06-28 | -$8.52B 10-Q · filed 2015-08-06 | |
| 2015-03-29 | -$8.56B 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$7.32B 10-K · filed 2016-02-29 | |
| 2014-09-28 | -$3.47B 10-Q · filed 2014-11-06 | |
| 2014-06-29 | -$3.15B 10-Q · filed 2014-08-07 | |
| 2014-03-30 | -$3.39B 10-Q · filed 2014-05-08 | |
| 2013-12-31 | -$3.27B 10-K · filed 2015-02-27 | |
| 2013-09-29 | -$6.38B 10-Q · filed 2013-11-08 | |
| 2013-06-30 | -$6.46B 10-Q · filed 2013-08-09 | |
| 2013-03-31 | -$6.16B 10-Q · filed 2013-05-10 | |
| 2012-12-31 | -$5.95B 10-K · filed 2014-02-28 | |
| 2012-09-30 | -$5.65B 10-Q · filed 2012-11-09 | |
| 2012-07-01 | -$6.01B 10-Q · filed 2012-08-09 | |
| 2012-04-01 | -$3.62B 10-Q · filed 2012-05-10 | |
| 2011-12-31 | -$4.13B 10-K · filed 2013-02-28 | |
| 2011-10-02 | -$1.21B 10-Q · filed 2011-11-10 | |
| 2011-07-03 | -$952.00M 10-Q · filed 2011-08-11 | |
| 2011-04-03 | -$2.06B 10-Q · filed 2011-05-12 | |
| 2010-12-31 | -$3.44B 10-K · filed 2012-02-28 | |
| 2010-10-03 | -$3.70B 10-Q · filed 2010-11-12 | |
| 2010-07-04 | -$4.41B 10-Q · filed 2010-08-12 | |
| 2010-04-04 | -$1.94B 10-Q · filed 2010-05-13 | |
| 2009-12-31 | $552.00M 10-K · filed 2011-02-28 | |
| 2009-09-27 | -$1.90B 10-Q · filed 2009-11-05 | |
| 2009-06-28 | -$2.08B 10-Q · filed 2009-08-06 | |
| 2008-12-31 | -$4.57B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |